GLOBUS MEDICAL, INC. (GMED) Gross margin 2016–2025
GLOBUS MEDICAL, INC. (GMED) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.4%FY2025 · since FY2016: 76.1% → 67.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.4% | +8.5 pp |
| FY2024 | 58.9% | -6.2 pp |
| FY2023 | 65.1% | -9.2 pp |
| FY2022 | 74.2% | -0.8 pp |
| FY2021 | 75.0% | +2.6 pp |
| FY2020 | 72.4% | -4.6 pp |
| FY2019 | 77.1% | -0.6 pp |
| FY2018 | 77.6% | +1.3 pp |
| FY2017 | 76.3% | +0.2 pp |
| FY2016 | 76.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GMED financial trends
GMED RevenueGMED Net incomeGMED Net marginGMED Gross profitGMED Operating incomeGMED Operating marginGMED Operating cash flowGMED Free cash flowGMED Capital expendituresGMED Return on equityGMED Stock buybacksGMED Dividends paidGMED Total assetsGMED Total liabilitiesGMED Shareholders’ equityGMED overview →